← Issue №20/ week of Nov 15, 2026/Colorectal

Comparative Outcomes of CREATE Versus Conventional Double-Stapling Technique for Ultralow Rectal Cancer: A Multicenter Propensity-Matched Analysis.

From GI Signals issue №20: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Colorectal retrospective · n=168 · Nov 12, 2026 · Dis Colon Rectum · IF 3.5

Comparative Outcomes of CREATE Versus Conventional Double-Stapling Technique for Ultralow Rectal Cancer: A Multicenter Propensity-Matched Analysis.

New evidencerectal cancercolorectal surgery
Clinical takeawayAn early functional advantage from a retrospective matched cohort with selective eligibility for CREATE and LARS assessed after stoma reversal; it was gone by 24 months, and anastomotic leakage and 3-year survival did not differ significantly.
What it foundIn a retrospective propensity-matched comparison (60 CREATE vs 108 double-stapling patients), major LARS was 42.9% vs 72.5% at 6 months (p=0.01) and 35.3% vs 66.7% at 12 months (p=0.007), with no difference at 24 months (p=1.00). Anastomoses were higher (3.0 vs 2.0 cm) and distal margins shorter (1.0 vs 1.2 cm); 3-year disease-free (88.4% vs 86.1%) and overall survival (89.3% vs 91.5%) did not differ significantly.
ContextCREATE (conformal resection after eversion with asymmetric twice stapling) was developed to refine distal transection and stapled coloanal anastomosis in ultralow rectal cancer; three Chinese tertiary centres, 2012 to 2021.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Hu G … Tang J · Diseases of the Colon and Rectum · IF 3.5 · PubMed ↗Permalink
← Read the whole of issue №20 Every paper GI Signals surfaces gets a page like this one. All issues